LON:EDEN Eden Research (EDEN) Share Price, News & Analysis GBX 2.37 -0.36 (-13.26%) As of 07:51 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsHeadlinesInsider TradesBuy This Stock About Eden Research Stock (LON:EDEN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Eden Research alerts:Sign Up Key Stats Today's Range 2.26▼ 2.6850-Day Range 2.73▼ 4.1252-Week Range 2.26▼ 5.22Volume1.70 million shsAverage Volume761,534 shsMarket Capitalization£12.63 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewEden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries. Eden's products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides. Eden has two products currently on the market: Based on plant-derived active ingredients, Mevalone ® is a foliar biofungicide which initially targets a key disease affecting grapes and other high-value fruit and vegetable crops. It is a useful tool in crop defence programmes and is aligned with the requirements of integrated pest management programmes. It is approved for sale in a number of key countries whilst Eden and its partners pursue regulatory clearance in new territories thereby growing Eden's addressable market globally. Cedroz ™ is a bionematicide that targets free living nematodes which are parasitic worms that affect a wide range of high-value fruit and vegetable crops globally. Cedroz is registered for sale on two continents and Eden's commercial collaborator, Eastman Chemical, is pursuing registration and commercialisation of this important new product in numerous countries globally. Eden's Sustaine ® encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease-of-use. Sustaine microcapsules are naturally-derived, plastic-free, biodegradable micro-spheres derived from yeast. It is one of the only viable, proven and immediately registerable solutions to the microplastics problem in formulations requiring encapsulation. Eden was admitted to trading on AIM on 11 May 2012 and trades under the symbol EDEN. It was awarded the London Stock Exchange Green Economy Mark in January 2021, which recognises London-listed companies that derive over 50% of their total annual revenue from products and services that contribute to the global green economy. Eden derives 100% of its total annual revenues from sustainable products and services. For more information about Eden, please visit: www.edenresearch.com .Read More… Remove Ads Receive EDEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Eden Research and its competitors with MarketBeat's FREE daily newsletter. Email Address EDEN Stock News HeadlinesEden Research plc (LON:EDEN) Insider Alexander John Abrey Purchases 167,947 SharesMarch 5, 2025 | insidertrades.comEden Research Enhances Brokerage Services with Oberon Capital AppointmentMarch 10, 2025 | msn.comGame Over for Tesla?Tesla is down 50% from its high... Our research indicates investors are waking up to the fact that Tesla is no longer Musk's #1 priority. His real goal is political power - and his private AI firm xAI. He recently bought over $1 billion worth of AI chips from NVIDIA... And is about to spend $5 billion on yet another data center for xAI.March 31, 2025 | Behind the Markets (Ad)NASA Scientists Harvested Food Crops in Antarctica For The First Time — Then, They Took a BiteMarch 9, 2025 | msn.comEden Research Chairman Increases Stake, Signaling Confidence in Sustainable GrowthMarch 5, 2025 | tipranks.comEden Research Director Increases Stake, Signaling Confidence in Sustainable BiopesticidesMarch 5, 2025 | tipranks.comMicrolight3D and Eden Tech form microfluidic solutions partnershipMarch 5, 2025 | msn.comEden Research Executives Increase Shareholdings, Reinforcing Commitment to Sustainable GrowthMarch 4, 2025 | tipranks.comSee More Headlines EDEN Stock Analysis - Frequently Asked Questions How have EDEN shares performed this year? Eden Research's stock was trading at GBX 3.90 at the start of the year. Since then, EDEN shares have decreased by 39.3% and is now trading at GBX 2.37. View the best growth stocks for 2025 here. How were Eden Research's earnings last quarter? Eden Research plc (LON:EDEN) announced its quarterly earnings results on Tuesday, September, 29th. The company reported ($0.40) earnings per share (EPS) for the quarter. Eden Research had a negative trailing twelve-month return on equity of 11.63% and a negative net margin of 38.70%. How do I buy shares of Eden Research? Shares of EDEN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Eden Research own? Based on aggregate information from My MarketBeat watchlists, some other companies that Eden Research investors own include Kromek Group (KMK), Primary Health Properties (PHP), National Grid (NG.L), Cabot Energy (CAB), EPE Special Opportunities (ESO), Marston's (MARS) and Mothercare (MTC). Company Calendar Last Earnings9/29/2020Today3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorBasic Materials Industry Agricultural Inputs Sub-IndustryN/A Current SymbolLON:EDEN CIKN/A Webwww.edenresearch.com Phone+44-1285-359555FaxN/AEmployees19Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.29) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-1,522,582.96 Net Margins-38.70% Pretax MarginN/A Return on Equity-11.63% Return on Assets-11.29% Debt Debt-to-Equity Ratio1.26 Current Ratio3.80 Quick Ratio2.42 Sales & Book Value Annual Sales£3.93 million Price / Sales3.52 Cash FlowGBX 0.22 per share Price / Cash Flow11.90 Book ValueGBX 2.38 per share Price / Book1.09Miscellaneous Outstanding Shares533,353,000Free FloatN/AMarket Cap£13.87 million OptionableNot Optionable Beta0.92 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (LON:EDEN) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eden Research plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Eden Research With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.